William E. Berger

California Allergy and Asthma Medical Group

Also affiliated with Center for Asthma, Allergy and Respiratory Disease

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)”.

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)

The Journal of Allergy and Clinical Immunology In Practice(2025)10.1016/j.jaip.2025.02.024

N/A

0.311DataRank · unranked

6 citations

Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown‐Whitehorn +29 more

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.11.017

N/A

0DataRank · unranked

62 citations

Rémi Gagnon, Gordon L. Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown‐Whitehorn +31 more